Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: Overview of methods
Open Access
- 3 November 2008
- Vol. 113 (S10), 2841-2854
- https://doi.org/10.1002/cncr.23758
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: The potential roleCancer, 2008
- Understanding the burden of human papillomavirus-associated anal cancers in the USCancer, 2008
- Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003Cancer, 2008
- Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United StatesCancer, 2008
- Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska NativesCancer, 2007
- Effect of Human Papillomavirus Vaccines on Vulvar, Vaginal, and Anal Intraepithelial Lesions and Vulvar CancerObstetrics & Gynecology, 2006
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic ReviewCancer Epidemiology, Biomarkers & Prevention, 2005
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004